Sensona is pioneering the future of molecular testing with patented ultrafast PCR technology.
By merging nanocrystals-driven platform, DNA nanotechnology, and intelligent design, we make PCR ultrafast, energy efficient, and more accessible than ever before.
At Sensona, PCR technology has no borders. We are driven by the goal of enabling PCR testing that is reliable, rapid, and globally available—from clinical laboratories and hospitals to schools, airports, and field settings. By improving access to molecular testing, we aim to strengthen global health systems, support faster decision-making, and address urgent challenges such as antibiotic resistance and emerging infectious threats.
PCR has long been considered the gold standard for detecting pathogens and genetic markers. With more than 20 years of combined expertise in nanotechnology and molecular diagnostics, Sensona builds upon this foundation to establish new benchmarks for PCR speed and simplicity, supported by multiple international patents.
We proudly introduce our 90-second qPCR solution—designed for speed and clarity with an intuitive, user-friendly workflow that’s as straightforward as an at-home pregnancy test.
Our founders and experts bring deep experience across science, product development, and commercialization. Drawing on two decades of collaborative success, they lead a dedicated team focused on translating breakthrough research into reliable, manufacturable products.
We are committed to advancing medical and biotechnology innovation—making high-performance molecular testing faster, easier to use, and accessible wherever it’s needed most.
Experience the future of rapid testing with SENSONA.
Schedule a demonstration and see how our 90-second PCR platform can revolutionize your workflow.
Revolutionizing rapid diagnostics through innovative nanotechnology.
Delivering 90-second PCR-based testing for infectious diseases at the point of care.
Get the latest news and updates from SENSONA